Literature DB >> 9889244

PCR targeted to the 16S-23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes.

S L Stubbs1, J S Brazier, G L O'Neill, B I Duerden.   

Abstract

A reference library of types of Clostridium difficile has been constructed by PCR ribotyping isolates (n = 2,030) from environmental (n = 89), hospital (n = 1,386), community practitioner (n = 395), veterinary (n = 27), and reference (n = 133) sources. The library consists of 116 distinct types identified on the basis of differences in profiles generated with PCR primers designed to amplify the 16S-23S rRNA gene intergenic spacer region. Isolates from 55% of infections in hospitals in the United Kingdom belonged to one ribotype (type 1), but this type was responsible for only 7. 5% of community infections.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9889244      PMCID: PMC84342     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  13 in total

1.  Immunoblots and plasmid fingerprints compared with serotyping and polyacrylamide gel electrophoresis for typing Clostridium difficile.

Authors:  M E Mulligan; L R Peterson; R Y Kwok; C R Clabots; D N Gerding
Journal:  J Clin Microbiol       Date:  1988-01       Impact factor: 5.948

2.  Comparison of PCR-based approaches to molecular epidemiologic analysis of Clostridium difficile.

Authors:  M C Collier; F Stock; P C DeGirolami; M H Samore; C P Cartwright
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

3.  Immunoblotting to demonstrate antigenic and immunogenic differences among nine standard strains of Clostridium difficile.

Authors:  S R Heard; B Rasburn; R C Matthews; S Tabaqchali
Journal:  J Clin Microbiol       Date:  1986-09       Impact factor: 5.948

Review 4.  Clostridium difficile: its disease and toxins.

Authors:  D M Lyerly; H C Krivan; T D Wilkins
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

5.  Use of the arbitrary primer polymerase chain reaction for investigating an outbreak of Clostridium difficile-associated diarrhea in AIDS patients.

Authors:  F Barbut; N Mario; J Frottier; J C Petit
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-10       Impact factor: 3.267

Review 6.  Role of the laboratory in investigations of Clostridium difficile diarrhea.

Authors:  J S Brazier
Journal:  Clin Infect Dis       Date:  1993-06       Impact factor: 9.079

7.  PCR amplification of rRNA intergenic spacer regions as a method for epidemiologic typing of Clostridium difficile.

Authors:  C P Cartwright; F Stock; S E Beekmann; E C Williams; V J Gill
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

8.  Serogrouping of Clostridium difficile strains by slide agglutination.

Authors:  M Delmee; M Homel; G Wauters
Journal:  J Clin Microbiol       Date:  1985-03       Impact factor: 5.948

9.  Serotyping of Clostridium difficile.

Authors:  S Toma; G Lesiak; M Magus; H L Lo; M Delmée
Journal:  J Clin Microbiol       Date:  1988-03       Impact factor: 5.948

10.  Typing of Clostridium difficile strains by PCR-amplification of variable length 16S-23S rDNA spacer regions.

Authors:  V Gürtler
Journal:  J Gen Microbiol       Date:  1993-12
View more
  163 in total

1.  Phenotypic and genotypic diversity of the flagellin gene (fliC) among Clostridium difficile isolates from different serogroups.

Authors:  A Tasteyre; T Karjalainen; V Avesani; M Delmée; A Collignon; P Bourlioux; M C Barc
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

2.  Evaluation of repetitive element sequence-based PCR as a molecular typing method for Clostridium difficile.

Authors:  Patrizia Spigaglia; Paola Mastrantonio
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

3.  Use of modified PCR ribotyping for direct detection of Clostridium difficile ribotypes in stool samples.

Authors:  Sandra Janezic; Iztok Strumbelj; Maja Rupnik
Journal:  J Clin Microbiol       Date:  2011-06-01       Impact factor: 5.948

4.  Pulsed-field gel electrophoresis can yield DNA fingerprints of degradation-susceptible Clostridium difficile strains.

Authors:  Warren N Fawley; Mark H Wilcox
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

5.  An enhanced DNA fingerprinting service to investigate potential Clostridium difficile infection case clusters sharing the same PCR ribotype.

Authors:  Warren N Fawley; Mark H Wilcox
Journal:  J Clin Microbiol       Date:  2011-09-28       Impact factor: 5.948

6.  Glutamate dehydrogenase is highly conserved among Clostridium difficile ribotypes.

Authors:  R J Carman; K N Wickham; L Chen; A M Lawrence; J H Boone; T D Wilkins; T M Kerkering; D M Lyerly
Journal:  J Clin Microbiol       Date:  2012-02-01       Impact factor: 5.948

7.  Frequent emergence of resistance in Clostridium difficile during treatment of C. difficile-associated diarrhea with fusidic acid.

Authors:  T Norén; M Wullt; Thomas Akerlund; E Bäck; I Odenholt; L G Burman
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

8.  Antimicrobial susceptibility pattern of Clostridium difficile and its relation to PCR ribotypes in a Swedish university hospital.

Authors:  Olle Aspevall; Annika Lundberg; Lars G Burman; Thomas Akerlund; Bo Svenungsson
Journal:  Antimicrob Agents Chemother       Date:  2006-05       Impact factor: 5.191

9.  Molecular analysis of Clostridium difficile PCR ribotype 027 isolates from Eastern and Western Canada.

Authors:  Duncan R MacCannell; Thomas J Louie; Dan B Gregson; Michel Laverdiere; Annie-Claude Labbe; Felicia Laing; Scott Henwick
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

10.  Epidemiology of Clostridium difficile-associated disease at University Hospital Basel including molecular characterisation of the isolates 2006-2007.

Authors:  L Fenner; R Frei; M Gregory; M Dangel; A Stranden; A F Widmer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-06-17       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.